Loading…
Development and Mechanism Studies of Cationic Chitosan-Modified Biodegradable PLGA Nanoparticles for Efficient siRNA Drug Delivery
Purpose In order to improve siRNA delivery for possible clinical applications, we developed biodegradable chitosan-modified poly(D,L-lactide-co-glycolide) (CHT-PLGA) nanoparticles with positive surface charge, high siRNA loading, high transfection efficiency and low toxicity. Methods CHT-PLGA nanopa...
Saved in:
Published in: | Pharmaceutical research 2010-07, Vol.27 (7), p.1285-1295 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c426t-6184835a464949abc9cf8d15177106af8234a7b0643d50a7411b9fea9ecd2b633 |
---|---|
cites | cdi_FETCH-LOGICAL-c426t-6184835a464949abc9cf8d15177106af8234a7b0643d50a7411b9fea9ecd2b633 |
container_end_page | 1295 |
container_issue | 7 |
container_start_page | 1285 |
container_title | Pharmaceutical research |
container_volume | 27 |
creator | Yuan, Xudong Shah, Bruhal A Kotadia, Naimesh K Li, Jian Gu, Hua Wu, Zhiqian |
description | Purpose In order to improve siRNA delivery for possible clinical applications, we developed biodegradable chitosan-modified poly(D,L-lactide-co-glycolide) (CHT-PLGA) nanoparticles with positive surface charge, high siRNA loading, high transfection efficiency and low toxicity. Methods CHT-PLGA nanoparticles were prepared, and siRNA was loaded by emulsion evaporation method with poly(vinyl alcohol) (PVA) as emulsifier. siRNA loading efficiency, particle size, and Zeta potential of nanoparticles were measured. Gel retardation and protection assays were conducted to determine the loading and binding of siRNA in the formulation. Cell transfection was performed to study in vitro siRNA silencing efficiency. XTT assay was used to evaluate the cytotoxicity. Results It was found that the nanoparticle diameter and positive Zeta potential increase as the chitosan coating concentration increases. CHT-PLGA nanoparticles showed excellent siRNA binding ability and effective protection of oligos from RNase degradation. siRNA-loaded nanoparticles were successfully delivered into the HEK 293 T cell line, and the silencing of green fluorescence protein (GFP) expression was observed using fluorescent microscopy and flow cytometry. In addition, the cytotoxicity assay revealed that CHT-PLGA nanoparticles had relatively low cytotoxicity. Conclusion This study suggests that biodegradable cationic CHT-PLGA nanoparticles possess great potential for efficient and safer siRNA delivery in future clinical applications. |
doi_str_mv | 10.1007/s11095-010-0103-0 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_744620988</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2057654151</sourcerecordid><originalsourceid>FETCH-LOGICAL-c426t-6184835a464949abc9cf8d15177106af8234a7b0643d50a7411b9fea9ecd2b633</originalsourceid><addsrcrecordid>eNp9kU9v1DAQxS0EokvhA3ABiwunwDh27Pi43W0L0rYgSiVuluM_W1dJvNhJpV77yUmUAhIHDqM5zO-9mdFD6DWBDwRAfMyEgKwKIDAXLeAJWpFK0EIC-_EUrUCUrKgFI0foRc63AFATyZ6joxIoSE74Cj1s3Z1r46Fz_YB1b_GFMze6D7nDV8Nog8s4erzRQ4h9MHhzE4aYdV9cRBt8cBafhGjdPmmrm9bhr7vzNb7UfTzoNATTTnIfEz71Ppgwr8jh2-Uab9O4x1vXhjuX7l-iZ1632b167Mfo-uz0--ZTsfty_nmz3hWGlXwoOKlZTSvNOJNM6sZI42tLKiIEAa59XVKmRQOcUVuBnr4mjfROS2ds2XBKj9H7xfeQ4s_R5UF1IRvXtrp3ccxKMMZLkHU9ke_-IW_jmPrpOEVFRUtWMZggskAmxZyT8-qQQqfTvSKg5njUEo-aopmLqlnz5tF4bDpn_yh-5zEB5QLkadTvXfq7-X-ubxeR11HpfQpZXV-VQCiQumKUV_QXgIqjIA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>375324540</pqid></control><display><type>article</type><title>Development and Mechanism Studies of Cationic Chitosan-Modified Biodegradable PLGA Nanoparticles for Efficient siRNA Drug Delivery</title><source>Springer Nature</source><creator>Yuan, Xudong ; Shah, Bruhal A ; Kotadia, Naimesh K ; Li, Jian ; Gu, Hua ; Wu, Zhiqian</creator><creatorcontrib>Yuan, Xudong ; Shah, Bruhal A ; Kotadia, Naimesh K ; Li, Jian ; Gu, Hua ; Wu, Zhiqian</creatorcontrib><description>Purpose In order to improve siRNA delivery for possible clinical applications, we developed biodegradable chitosan-modified poly(D,L-lactide-co-glycolide) (CHT-PLGA) nanoparticles with positive surface charge, high siRNA loading, high transfection efficiency and low toxicity. Methods CHT-PLGA nanoparticles were prepared, and siRNA was loaded by emulsion evaporation method with poly(vinyl alcohol) (PVA) as emulsifier. siRNA loading efficiency, particle size, and Zeta potential of nanoparticles were measured. Gel retardation and protection assays were conducted to determine the loading and binding of siRNA in the formulation. Cell transfection was performed to study in vitro siRNA silencing efficiency. XTT assay was used to evaluate the cytotoxicity. Results It was found that the nanoparticle diameter and positive Zeta potential increase as the chitosan coating concentration increases. CHT-PLGA nanoparticles showed excellent siRNA binding ability and effective protection of oligos from RNase degradation. siRNA-loaded nanoparticles were successfully delivered into the HEK 293 T cell line, and the silencing of green fluorescence protein (GFP) expression was observed using fluorescent microscopy and flow cytometry. In addition, the cytotoxicity assay revealed that CHT-PLGA nanoparticles had relatively low cytotoxicity. Conclusion This study suggests that biodegradable cationic CHT-PLGA nanoparticles possess great potential for efficient and safer siRNA delivery in future clinical applications.</description><identifier>ISSN: 0724-8741</identifier><identifier>EISSN: 1573-904X</identifier><identifier>DOI: 10.1007/s11095-010-0103-0</identifier><identifier>PMID: 20309616</identifier><language>eng</language><publisher>Boston: Boston : Springer US</publisher><subject>Biochemistry ; Biodegradation ; Biomedical and Life Sciences ; Biomedical Engineering and Bioengineering ; Biomedicine ; Cell Line ; Cell Survival - drug effects ; chitosan ; Chitosan - chemistry ; Drug Delivery Systems ; Humans ; Lactic Acid - administration & dosage ; Lactic Acid - chemical synthesis ; Lactic Acid - chemistry ; Lactic Acid - pharmacology ; Medical Law ; Models, Biological ; Nanoparticles ; Nanoparticles - administration & dosage ; Nanoparticles - chemistry ; nanotechnology ; Particle Size ; Pharmacology ; Pharmacology/Toxicology ; Pharmacy ; poly(D,L-lactide-co-glycolide) (PLGA) ; Polyglycolic Acid - administration & dosage ; Polyglycolic Acid - chemical synthesis ; Polyglycolic Acid - chemistry ; Polyglycolic Acid - pharmacology ; Research Paper ; Ribonucleic acid ; RNA ; RNA, Small Interfering - administration & dosage ; RNA, Small Interfering - chemistry ; RNA, Small Interfering - pharmacology ; siRNA delivery ; Toxicity</subject><ispartof>Pharmaceutical research, 2010-07, Vol.27 (7), p.1285-1295</ispartof><rights>Springer Science+Business Media, LLC 2010</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c426t-6184835a464949abc9cf8d15177106af8234a7b0643d50a7411b9fea9ecd2b633</citedby><cites>FETCH-LOGICAL-c426t-6184835a464949abc9cf8d15177106af8234a7b0643d50a7411b9fea9ecd2b633</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27900,27901</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20309616$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yuan, Xudong</creatorcontrib><creatorcontrib>Shah, Bruhal A</creatorcontrib><creatorcontrib>Kotadia, Naimesh K</creatorcontrib><creatorcontrib>Li, Jian</creatorcontrib><creatorcontrib>Gu, Hua</creatorcontrib><creatorcontrib>Wu, Zhiqian</creatorcontrib><title>Development and Mechanism Studies of Cationic Chitosan-Modified Biodegradable PLGA Nanoparticles for Efficient siRNA Drug Delivery</title><title>Pharmaceutical research</title><addtitle>Pharm Res</addtitle><addtitle>Pharm Res</addtitle><description>Purpose In order to improve siRNA delivery for possible clinical applications, we developed biodegradable chitosan-modified poly(D,L-lactide-co-glycolide) (CHT-PLGA) nanoparticles with positive surface charge, high siRNA loading, high transfection efficiency and low toxicity. Methods CHT-PLGA nanoparticles were prepared, and siRNA was loaded by emulsion evaporation method with poly(vinyl alcohol) (PVA) as emulsifier. siRNA loading efficiency, particle size, and Zeta potential of nanoparticles were measured. Gel retardation and protection assays were conducted to determine the loading and binding of siRNA in the formulation. Cell transfection was performed to study in vitro siRNA silencing efficiency. XTT assay was used to evaluate the cytotoxicity. Results It was found that the nanoparticle diameter and positive Zeta potential increase as the chitosan coating concentration increases. CHT-PLGA nanoparticles showed excellent siRNA binding ability and effective protection of oligos from RNase degradation. siRNA-loaded nanoparticles were successfully delivered into the HEK 293 T cell line, and the silencing of green fluorescence protein (GFP) expression was observed using fluorescent microscopy and flow cytometry. In addition, the cytotoxicity assay revealed that CHT-PLGA nanoparticles had relatively low cytotoxicity. Conclusion This study suggests that biodegradable cationic CHT-PLGA nanoparticles possess great potential for efficient and safer siRNA delivery in future clinical applications.</description><subject>Biochemistry</subject><subject>Biodegradation</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedical Engineering and Bioengineering</subject><subject>Biomedicine</subject><subject>Cell Line</subject><subject>Cell Survival - drug effects</subject><subject>chitosan</subject><subject>Chitosan - chemistry</subject><subject>Drug Delivery Systems</subject><subject>Humans</subject><subject>Lactic Acid - administration & dosage</subject><subject>Lactic Acid - chemical synthesis</subject><subject>Lactic Acid - chemistry</subject><subject>Lactic Acid - pharmacology</subject><subject>Medical Law</subject><subject>Models, Biological</subject><subject>Nanoparticles</subject><subject>Nanoparticles - administration & dosage</subject><subject>Nanoparticles - chemistry</subject><subject>nanotechnology</subject><subject>Particle Size</subject><subject>Pharmacology</subject><subject>Pharmacology/Toxicology</subject><subject>Pharmacy</subject><subject>poly(D,L-lactide-co-glycolide) (PLGA)</subject><subject>Polyglycolic Acid - administration & dosage</subject><subject>Polyglycolic Acid - chemical synthesis</subject><subject>Polyglycolic Acid - chemistry</subject><subject>Polyglycolic Acid - pharmacology</subject><subject>Research Paper</subject><subject>Ribonucleic acid</subject><subject>RNA</subject><subject>RNA, Small Interfering - administration & dosage</subject><subject>RNA, Small Interfering - chemistry</subject><subject>RNA, Small Interfering - pharmacology</subject><subject>siRNA delivery</subject><subject>Toxicity</subject><issn>0724-8741</issn><issn>1573-904X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNp9kU9v1DAQxS0EokvhA3ABiwunwDh27Pi43W0L0rYgSiVuluM_W1dJvNhJpV77yUmUAhIHDqM5zO-9mdFD6DWBDwRAfMyEgKwKIDAXLeAJWpFK0EIC-_EUrUCUrKgFI0foRc63AFATyZ6joxIoSE74Cj1s3Z1r46Fz_YB1b_GFMze6D7nDV8Nog8s4erzRQ4h9MHhzE4aYdV9cRBt8cBafhGjdPmmrm9bhr7vzNb7UfTzoNATTTnIfEz71Ppgwr8jh2-Uab9O4x1vXhjuX7l-iZ1632b167Mfo-uz0--ZTsfty_nmz3hWGlXwoOKlZTSvNOJNM6sZI42tLKiIEAa59XVKmRQOcUVuBnr4mjfROS2ds2XBKj9H7xfeQ4s_R5UF1IRvXtrp3ccxKMMZLkHU9ke_-IW_jmPrpOEVFRUtWMZggskAmxZyT8-qQQqfTvSKg5njUEo-aopmLqlnz5tF4bDpn_yh-5zEB5QLkadTvXfq7-X-ubxeR11HpfQpZXV-VQCiQumKUV_QXgIqjIA</recordid><startdate>20100701</startdate><enddate>20100701</enddate><creator>Yuan, Xudong</creator><creator>Shah, Bruhal A</creator><creator>Kotadia, Naimesh K</creator><creator>Li, Jian</creator><creator>Gu, Hua</creator><creator>Wu, Zhiqian</creator><general>Boston : Springer US</general><general>Springer US</general><general>Springer Nature B.V</general><scope>FBQ</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7QO</scope><scope>7TM</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>20100701</creationdate><title>Development and Mechanism Studies of Cationic Chitosan-Modified Biodegradable PLGA Nanoparticles for Efficient siRNA Drug Delivery</title><author>Yuan, Xudong ; Shah, Bruhal A ; Kotadia, Naimesh K ; Li, Jian ; Gu, Hua ; Wu, Zhiqian</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c426t-6184835a464949abc9cf8d15177106af8234a7b0643d50a7411b9fea9ecd2b633</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Biochemistry</topic><topic>Biodegradation</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedical Engineering and Bioengineering</topic><topic>Biomedicine</topic><topic>Cell Line</topic><topic>Cell Survival - drug effects</topic><topic>chitosan</topic><topic>Chitosan - chemistry</topic><topic>Drug Delivery Systems</topic><topic>Humans</topic><topic>Lactic Acid - administration & dosage</topic><topic>Lactic Acid - chemical synthesis</topic><topic>Lactic Acid - chemistry</topic><topic>Lactic Acid - pharmacology</topic><topic>Medical Law</topic><topic>Models, Biological</topic><topic>Nanoparticles</topic><topic>Nanoparticles - administration & dosage</topic><topic>Nanoparticles - chemistry</topic><topic>nanotechnology</topic><topic>Particle Size</topic><topic>Pharmacology</topic><topic>Pharmacology/Toxicology</topic><topic>Pharmacy</topic><topic>poly(D,L-lactide-co-glycolide) (PLGA)</topic><topic>Polyglycolic Acid - administration & dosage</topic><topic>Polyglycolic Acid - chemical synthesis</topic><topic>Polyglycolic Acid - chemistry</topic><topic>Polyglycolic Acid - pharmacology</topic><topic>Research Paper</topic><topic>Ribonucleic acid</topic><topic>RNA</topic><topic>RNA, Small Interfering - administration & dosage</topic><topic>RNA, Small Interfering - chemistry</topic><topic>RNA, Small Interfering - pharmacology</topic><topic>siRNA delivery</topic><topic>Toxicity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yuan, Xudong</creatorcontrib><creatorcontrib>Shah, Bruhal A</creatorcontrib><creatorcontrib>Kotadia, Naimesh K</creatorcontrib><creatorcontrib>Li, Jian</creatorcontrib><creatorcontrib>Gu, Hua</creatorcontrib><creatorcontrib>Wu, Zhiqian</creatorcontrib><collection>AGRIS</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>ProQuest Health & Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health & Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Biotechnology Research Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Pharmaceutical research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yuan, Xudong</au><au>Shah, Bruhal A</au><au>Kotadia, Naimesh K</au><au>Li, Jian</au><au>Gu, Hua</au><au>Wu, Zhiqian</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Development and Mechanism Studies of Cationic Chitosan-Modified Biodegradable PLGA Nanoparticles for Efficient siRNA Drug Delivery</atitle><jtitle>Pharmaceutical research</jtitle><stitle>Pharm Res</stitle><addtitle>Pharm Res</addtitle><date>2010-07-01</date><risdate>2010</risdate><volume>27</volume><issue>7</issue><spage>1285</spage><epage>1295</epage><pages>1285-1295</pages><issn>0724-8741</issn><eissn>1573-904X</eissn><abstract>Purpose In order to improve siRNA delivery for possible clinical applications, we developed biodegradable chitosan-modified poly(D,L-lactide-co-glycolide) (CHT-PLGA) nanoparticles with positive surface charge, high siRNA loading, high transfection efficiency and low toxicity. Methods CHT-PLGA nanoparticles were prepared, and siRNA was loaded by emulsion evaporation method with poly(vinyl alcohol) (PVA) as emulsifier. siRNA loading efficiency, particle size, and Zeta potential of nanoparticles were measured. Gel retardation and protection assays were conducted to determine the loading and binding of siRNA in the formulation. Cell transfection was performed to study in vitro siRNA silencing efficiency. XTT assay was used to evaluate the cytotoxicity. Results It was found that the nanoparticle diameter and positive Zeta potential increase as the chitosan coating concentration increases. CHT-PLGA nanoparticles showed excellent siRNA binding ability and effective protection of oligos from RNase degradation. siRNA-loaded nanoparticles were successfully delivered into the HEK 293 T cell line, and the silencing of green fluorescence protein (GFP) expression was observed using fluorescent microscopy and flow cytometry. In addition, the cytotoxicity assay revealed that CHT-PLGA nanoparticles had relatively low cytotoxicity. Conclusion This study suggests that biodegradable cationic CHT-PLGA nanoparticles possess great potential for efficient and safer siRNA delivery in future clinical applications.</abstract><cop>Boston</cop><pub>Boston : Springer US</pub><pmid>20309616</pmid><doi>10.1007/s11095-010-0103-0</doi><tpages>11</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0724-8741 |
ispartof | Pharmaceutical research, 2010-07, Vol.27 (7), p.1285-1295 |
issn | 0724-8741 1573-904X |
language | eng |
recordid | cdi_proquest_miscellaneous_744620988 |
source | Springer Nature |
subjects | Biochemistry Biodegradation Biomedical and Life Sciences Biomedical Engineering and Bioengineering Biomedicine Cell Line Cell Survival - drug effects chitosan Chitosan - chemistry Drug Delivery Systems Humans Lactic Acid - administration & dosage Lactic Acid - chemical synthesis Lactic Acid - chemistry Lactic Acid - pharmacology Medical Law Models, Biological Nanoparticles Nanoparticles - administration & dosage Nanoparticles - chemistry nanotechnology Particle Size Pharmacology Pharmacology/Toxicology Pharmacy poly(D,L-lactide-co-glycolide) (PLGA) Polyglycolic Acid - administration & dosage Polyglycolic Acid - chemical synthesis Polyglycolic Acid - chemistry Polyglycolic Acid - pharmacology Research Paper Ribonucleic acid RNA RNA, Small Interfering - administration & dosage RNA, Small Interfering - chemistry RNA, Small Interfering - pharmacology siRNA delivery Toxicity |
title | Development and Mechanism Studies of Cationic Chitosan-Modified Biodegradable PLGA Nanoparticles for Efficient siRNA Drug Delivery |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-24T10%3A18%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Development%20and%20Mechanism%20Studies%20of%20Cationic%20Chitosan-Modified%20Biodegradable%20PLGA%20Nanoparticles%20for%20Efficient%20siRNA%20Drug%20Delivery&rft.jtitle=Pharmaceutical%20research&rft.au=Yuan,%20Xudong&rft.date=2010-07-01&rft.volume=27&rft.issue=7&rft.spage=1285&rft.epage=1295&rft.pages=1285-1295&rft.issn=0724-8741&rft.eissn=1573-904X&rft_id=info:doi/10.1007/s11095-010-0103-0&rft_dat=%3Cproquest_cross%3E2057654151%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c426t-6184835a464949abc9cf8d15177106af8234a7b0643d50a7411b9fea9ecd2b633%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=375324540&rft_id=info:pmid/20309616&rfr_iscdi=true |